No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs12986438 |
chr2:11220127-11220128 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs562532654 |
chr2:11220186-11220187 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs147150630 |
chr2:11220215-11220216 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs112686086 |
chr2:11220227-11220228 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs183933977 |
chr2:11220233-11220234 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs186441860 |
chr2:11220238-11220239 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs377166767 |
chr2:11220242-11220243 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs115701747 |
chr2:11220254-11220255 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs570419616 |
chr2:11220259-11220260 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs112002231 |
chr2:11220261-11220262 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs549583600 |
chr2:11220265-11220266 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs534629984 |
chr2:11220287-11220288 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs557614483 |
chr2:11220291-11220292 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs189676422 |
chr2:11220294-11220295 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs182276330 |
chr2:11220295-11220296 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs572399675 |
chr2:11220298-11220299 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs539450109 |
chr2:11220302-11220303 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs536666610 |
chr2:11220310-11220311 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs556866797 |
chr2:11220314-11220315 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs186980167 |
chr2:11220318-11220319 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs149699794 |
chr2:11220322-11220323 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs55730272 |
chr2:11220326-11220327 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs371653171 |
chr2:11220329-11220330 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs55695647 |
chr2:11220330-11220331 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs75529155 |
chr2:11220334-11220335 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs544003124 |
chr2:11220335-11220336 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs562243136 |
chr2:11220338-11220339 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs554754868 |
chr2:11220340-11220341 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs139339099 |
chr2:11220341-11220342 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs574317491 |
chr2:11220342-11220343 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs70953359 |
chr2:11220348-11220349 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs541898526 |
chr2:11220349-11220350 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs560038885 |
chr2:11220350-11220351 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs192874211 |
chr2:11220351-11220352 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs200770286 |
chr2:11220354-11220355 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs146485072 |
chr2:11220355-11220356 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs112787365 |
chr2:11220359-11220360 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs144868727 |
chr2:11220422-11220423 |
Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs183147567 |
chr2:11220429-11220430 |
Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs567900763 |
chr2:11220543-11220544 |
Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs529121237 |
chr2:11220556-11220557 |
Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs6739054 |
chr2:11220562-11220563 |
Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundancedisease
|
43 |
rs146796167 |
chr2:11220577-11220578 |
Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs539783501 |
chr2:11220604-11220605 |
Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs140432883 |
chr2:11220651-11220652 |
Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs371581570 |
chr2:11220676-11220677 |
Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs570092710 |
chr2:11220709-11220710 |
Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs150434104 |
chr2:11220810-11220811 |
Bivalent/Poised TSS Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs6724670 |
chr2:11220831-11220832 |
Bivalent/Poised TSS Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs138185488 |
chr2:11220855-11220856 |
Bivalent/Poised TSS Enhancers Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|